
Glabort Pharma Private Limited
About Glabort Pharma Private Limited
Data last updated:
Glabort Pharma Private Limited is a private limited company based in Mawana, Uttar Pradesh, India. It operates in the paper and paper products segment of the paper and packaging sector. It was incorporated on 09 February 2023.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U21009UP2023PTC177508.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rahul Kumar and Nirmala Sharma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Khajuri Alyarpur, Mawana, Uttar Pradesh, India – 250406.
As per the financials filed for FY 2024, the company reported a revenue of ₹16.25 Lakh. For the same year it recorded a net profit of ₹38,579 (net margin 2.4%) and EBITDA of ₹54,629 (EBITDA margin 3.4%).
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressKhajuri Alyarpur, Mawana, Uttar Pradesh, India – 250406
- IndustryPaper, Paper & Paper Products, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Glabort Pharma Private Limited
The main business activity of Glabort Pharma is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale and retail trade and repair of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 45 | Wholesale and retail trade and repair of motor vehicles and motorcycles | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Glabort Pharma Private Limited FY 2025 filings available
Glabort Pharma Private Limited reported revenue of ₹16.25 Lakh for FY 2024.
Financial Statement Summary of Glabort Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | •••• |
| Other Income | •••• | •••• |
| Total Revenue | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• |
| Employee Benefit Expense | •••• | •••• |
| Finance Costs | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• |
| Other Expenses | •••• | •••• |
| Total Expenses | •••• | •••• |
| EBITDA | ₹54,629 | •••• |
| Profit Before Tax | •••• | •••• |
| Tax Expense | •••• | •••• |
| Net Profit (PAT) | ₹38,579 | •••• |
| Balance Sheet | ||
| Share Capital | •••• | •••• |
| Reserves and Surplus | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• |
| Long-term Borrowings | •••• | •••• |
| Short-term Borrowings | •••• | •••• |
| Trade Payables | •••• | •••• |
| Total Liabilities | •••• | •••• |
| Fixed Assets | •••• | •••• |
| Investments | •••• | •••• |
| Inventories | •••• | •••• |
| Trade Receivables | •••• | •••• |
| Cash and Bank Balance | •••• | •••• |
| Total Assets | •••• | •••• |
Financial Ratios of Glabort Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 3.4% | •••• |
| Net Profit Margin | 2.4% | •••• |
| Return on Equity (ROE) | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• |
| Liquidity and Debt | ||
| Current Ratio | •••• | •••• |
| Quick Ratio | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• |
| Efficiency and Growth | ||
| Asset Turnover | •••• | •••• |
| Receivable Days | •••• | •••• |
| Payable Days | •••• | •••• |
| Inventory Days | •••• | •••• |
| Revenue Growth | •••• | •••• |
| Net Profit Growth | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Glabort Pharma are in the company report.
Financial statements from FY 2023
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Glabort Pharma Private Limited
Glabort Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rahul Kumar | Director | 09 Feb 2023 | 3 Years 8 Months | Current |
| Nirmala Sharma | Director | 09 Feb 2023 | 3 Years 8 Months | Current |
Peer Comparison of Glabort Pharma Private Limited
Glabort Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale and retail trade and repair of motor vehicles and motorcycles). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vaaki Sunrise Foundation | ₹16.44 Lakh (FY 2025) | •••• | •••• | 50.0% | •••• | Meerut, Uttar Pradesh, India |
| Digvijay Pharma Ceuticals India Private Limited | ₹16.36 Lakh (FY 2025) | •••• | •••• | -67.0% | •••• | Thane, Maharashtra, India |
| Sai Medisoft Private Limited. | ₹16.36 Lakh (FY 2025) | •••• | •••• | -18.0% | •••• | New Delhi, Delhi, India |
| Toddlerooze Sports Private Limited | ₹16.31 Lakh (FY 2025) | •••• | •••• | •••• | Lucknow, Uttar Pradesh, India | |
| Genix Concept Private Limited | ₹16.25 Lakh (FY 2025) | •••• | •••• | 34034.0% | •••• | Rajkot, Gujarat, India |
| Glabort Pharma Private Limited this company | ₹16.25 Lakh (FY 2024) | •••• | •••• | •••• | Mawana, Uttar Pradesh, India | |
| VLM Surendranagar SPNF Producer Company Limited | ₹16.22 Lakh (FY 2023) | •••• | •••• | •••• | Sarla, Gujarat, India | |
| Prrintsupport Services Private Limited | ₹16.22 Lakh (FY 2024) | •••• | •••• | -10.0% | •••• | Mumbai, Maharashtra, India |
| Shoppers Clinic Private Limited | ₹16.21 Lakh (FY 2025) | •••• | •••• | 10149.0% | •••• | Ghaziabad, Uttar Pradesh, India |
| Uhlr Solutions Private Limited | ₹16.19 Lakh (FY 2024) | •••• | •••• | 99.0% | •••• | Delhi, India |
| Jessandra Solar (OPC) Private Limited | ₹16.17 Lakh (FY 2025) | •••• | •••• | 353.0% | •••• | Chennai, Tamil Nadu, India |
Peers are the five companies nearest above and the five nearest below Glabort Pharma by revenue in the same principal business activity (Wholesale and retail trade and repair of motor vehicles and motorcycles), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Charges & Borrowings of Glabort Pharma Private Limited
Glabort Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Glabort Pharma Private Limited
Employment history and EPFO contributions of people linked to Glabort Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Glabort Pharma Private Limited
Glabort Pharma Private Limited has 2 board changes on record since 2023: 2 appointments. The latest: Nirmala Sharma was appointed as Director on 09 Feb 2023.
Credit Ratings, Litigation & Regulatory Alerts for Glabort Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Glabort Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Glabort Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Glabort Pharma Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Glabort Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Glabort Pharma Private Limited
Glabort Pharma is an active private limited company based in Mawana, Uttar Pradesh, India. The company works in paper and paper products, within the paper industry. It was incorporated on 09 February 2023 (3+ years old) and is registered under CIN U21009UP2023PTC177508.
Glabort Pharma reported revenue of ₹16.25 Lakh for FY 2024.
Glabort Pharma has 2 current directors:
- Rahul Kumar - Director
- Nirmala Sharma - Director
Glabort Pharma reported a net profit of ₹38,579 (net margin 2.4%) and EBITDA of ₹54,629 (EBITDA margin 3.4%) for FY 2024, as per its filed financial statements.
The CIN (Corporate Identification Number) of Glabort Pharma is U21009UP2023PTC177508. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Glabort Pharma was incorporated on 09 February 2023, making it 3+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Glabort Pharma by revenue are Vaaki Sunrise Foundation, Digvijay Pharma Ceuticals India Private Limited, Sai Medisoft Private Limited, Toddlerooze Sports Private Limited, Genix Concept Private Limited and 5 more, all in the same principal business activity (Wholesale and retail trade and repair of motor vehicles and motorcycles).
Nirmala Sharma was appointed as Director on 09 Feb 2023. Rahul Kumar was appointed as Director on 09 Feb 2023.
The registered office of Glabort Pharma is at Khajuri Alyarpur, Mawana, Uttar Pradesh, India – 250406.
Glabort Pharma has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh.
Glabort Pharma operates in the paper industry, in the paper and paper products segment.